Aptamimetics

Aptamimetics was founded in December 2020, driven by a vision: to overcome the limited availability and shortage of next-generation therapies and cultured foods for today's patients and customers. That's why we develop highly specific API products and bioactive compounds that enable biotech manufacturers to produce better products more easily.

Website

https://www.aptamimetics.com

Externer Link zu Aptamimetics

Branche

Biotechnologieforschung

Größe

2–10 Beschäftigte

Hauptsitz

Stegen, Baden-Württemberg

Art

Kapitalgesellschaft (AG, GmbH, UG etc.)

Gegründet

2020

Spezialgebiete

biotech, researchanddevelopment und biopharmaceuticals